Literature DB >> 24240656

Estimating the per-exposure effect of infectious disease interventions.

Justin J O'Hagan1, Marc Lipsitch, Miguel A Hernán.   

Abstract

The average effect of an infectious disease intervention (eg, a vaccine) varies across populations with different degrees of exposure to the pathogen. As a result, many investigators favor a per-exposure effect measure that is considered independent of the population level of exposure and that can be used in simulations to estimate the total disease burden averted by an intervention across different populations. However, while per-exposure effects are frequently estimated, the quantity of interest is often poorly defined, and assumptions in its calculation are typically left implicit. In this article, we build upon work by Halloran and Struchiner (Epidemiology. 1995;6:142-151) to develop a formal definition of the per-exposure effect and discuss conditions necessary for its unbiased estimation. With greater care paid to the parameterization of transmission models, their results can be better understood and can thereby be of greater value to decision-makers.

Entities:  

Mesh:

Year:  2014        PMID: 24240656      PMCID: PMC3898464          DOI: 10.1097/EDE.0000000000000003

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  37 in total

1.  Estimation of individual and population vaccination effectiveness from time-to-event data.

Authors:  M Haber; A Ndikuyeze
Journal:  Stat Med       Date:  1998-11-30       Impact factor: 2.373

Review 2.  Should we adjust for covariates in nonlinear regression analyses of randomized trials?

Authors:  W W Hauck; S Anderson; S M Marcus
Journal:  Control Clin Trials       Date:  1998-06

3.  Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.

Authors:  Tyler J Vanderweele; Onyebuchi A Arah
Journal:  Epidemiology       Date:  2011-01       Impact factor: 4.822

4.  Identifiability, exchangeability, and epidemiological confounding.

Authors:  S Greenland; J M Robins
Journal:  Int J Epidemiol       Date:  1986-09       Impact factor: 7.196

5.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

6.  Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.

Authors:  Clayton Harro; Subhra Chakraborty; Andrea Feller; Barbara DeNearing; Alicia Cage; Malathi Ram; Anna Lundgren; Ann-Mari Svennerholm; August L Bourgeois; Richard I Walker; David A Sack
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

7.  Cholera modeling: challenges to quantitative analysis and predicting the impact of interventions.

Authors:  Yonatan H Grad; Joel C Miller; Marc Lipsitch
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

8.  Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine.

Authors:  Mitchell B Cohen; Ralph A Giannella; Judy Bean; David N Taylor; Susan Parker; Amy Hoeper; Stephen Wowk; Jennifer Hawkins; Sims K Kochi; Gilbert Schiff; Kevin P Killeen
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

9.  The hazards of hazard ratios.

Authors:  Miguel A Hernán
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  Causal inference in infectious diseases.

Authors:  M E Halloran; C J Struchiner
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

View more
  12 in total

1.  A compelling demonstration of why traditional statistical regression models cannot be used to identify risk factors from case data on infectious diseases: a simulation study.

Authors:  Solveig Engebretsen; Gunnar Rø; Birgitte Freiesleben de Blasio
Journal:  BMC Med Res Methodol       Date:  2022-05-20       Impact factor: 4.612

2.  Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.

Authors:  Rebecca Kahn; Matt Hitchings; Steven Bellan; Marc Lipsitch
Journal:  Clin Trials       Date:  2018-01-27       Impact factor: 2.486

3.  Risk ratios for contagious outcomes.

Authors:  Olga Morozova; Ted Cohen; Forrest W Crawford
Journal:  J R Soc Interface       Date:  2018-01-17       Impact factor: 4.293

4.  Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence.

Authors:  M Gabriela M Gomes; Stephen B Gordon; David G Lalloo
Journal:  Vaccine       Date:  2016-05-10       Impact factor: 3.641

5.  Simulations for designing and interpreting intervention trials in infectious diseases.

Authors:  M Elizabeth Halloran; Kari Auranen; Sarah Baird; Nicole E Basta; Steven E Bellan; Ron Brookmeyer; Ben S Cooper; Victor DeGruttola; James P Hughes; Justin Lessler; Eric T Lofgren; Ira M Longini; Jukka-Pekka Onnela; Berk Özler; George R Seage; Thomas A Smith; Alessandro Vespignani; Emilia Vynnycky; Marc Lipsitch
Journal:  BMC Med       Date:  2017-12-29       Impact factor: 8.775

6.  A Dynamic Transmission Model to Evaluate the Effectiveness of Infection Control Strategies.

Authors:  Karim Khader; Alun Thomas; W Charles Huskins; Molly Leecaster; Yue Zhang; Tom Greene; Andrew Redd; Matthew H Samore
Journal:  Open Forum Infect Dis       Date:  2017-02-10       Impact factor: 3.835

7.  Vaccine Effects on Heterogeneity in Susceptibility and Implications for Population Health Management.

Authors:  Kate E Langwig; Andrew R Wargo; Darbi R Jones; Jessie R Viss; Barbara J Rutan; Nicholas A Egan; Pedro Sá-Guimarães; Min Sun Kim; Gael Kurath; M Gabriela M Gomes; Marc Lipsitch
Journal:  MBio       Date:  2017-11-21       Impact factor: 7.867

8.  Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implications.

Authors:  Joseph A Lewnard; Benjamin A Lopman; Umesh D Parashar; Aisleen Bennett; Naor Bar-Zeev; Nigel A Cunliffe; Prasanna Samuel; M Lourdes Guerrero; Guillermo Ruiz-Palacios; Gagandeep Kang; Virginia E Pitzer
Journal:  PLoS Comput Biol       Date:  2019-07-26       Impact factor: 4.475

9.  Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms.

Authors:  Guido España; Cosmina Hogea; Adrienne Guignard; Quirine A Ten Bosch; Amy C Morrison; David L Smith; Thomas W Scott; Alexander Schmidt; T Alex Perkins
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

10.  Modelling the Effectiveness of Epidemic Control Measures in Preventing the Transmission of COVID-19 in Malaysia.

Authors:  Balvinder Singh Gill; Vivek Jason Jayaraj; Sarbhan Singh; Sumarni Mohd Ghazali; Yoon Ling Cheong; Nuur Hafizah Md Iderus; Bala Murali Sundram; Tahir Bin Aris; Hishamshah Mohd Ibrahim; Boon Hao Hong; Jane Labadin
Journal:  Int J Environ Res Public Health       Date:  2020-07-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.